Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting

Principles and Practice of Endocrinology and Metabolism.

Annals of Internal Medicine · 1991 · 808 citations

Medicine, Endocrinology, Molecular Medicine +17

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla et al. · Journal of Clinical Oncology · 2003 · 776 citations

Medicine, Pharmacology, Pharmacotherapy +17

Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

Richard J. Gralla, Loretta M. Itri, Sharon E. Pisko et al. · New England Journal of Medicine · 1981 · 710 citations

Medicine, Pharmacology, Pharmacotherapy +17

Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

Richard J. Gralla, David Osoba, Mark G. Kris et al. · Journal of Clinical Oncology · 1999 · 670 citations

Medicine, Oncology, Pharmacotherapy +15

American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

Martee L. Hensley, Karen L. Hagerty, Tarun Kewalramani et al. · Journal of Clinical Oncology · 2008 · 538 citations

Medicine, Oncology, Radiation Oncology +17